Induction of mucosal immunity with a replication-defective adenoviral recombinant

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 2003-2008

  Xiang, Zhiquan ^a   Ertl, Hildegund C J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Mucosal immunity; Recombinant vaccine; Vaccines

Indexed keywords

RABIES VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; INTESTINE SECRETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES VIRUS; RECTUM MUCOSA; RESPIRATORY TRACT MUCOSA; VIRUS IMMUNITY; VIRUS INDUCTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; DEFECTIVE VIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GLYCOPROTEINS; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MICE, INBRED C3H; RABIES VACCINES; RABIES VIRUS; RECTUM; VACCINES, SYNTHETIC; VAGINA; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033537990     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00449-6     Document Type: Article

References (18)

1. Lehner T., Wang Y., Cranage M., Bergmeier L., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R., Klavinskis L., Jones I., Doyle C., Ward R. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:1996;767-775.
2. Xiang Z., Yang Y., Wilson J., Ertl H.C.J. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology. 219:1996;220-227.
3. Yang Y., Ertl H., Wilson J.M. MHC class I-restricted cytotoxic T-lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity. 1:1994;433-442.
4. Yang Y., Li Q., Ertl H., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung directed gene therapy with recombinant adenovirus. J. Virol. 69:1995;2004-2015.
5. Yang Y., Jooss K., Su Q., Ertl H., Wilson J.M. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus infected hepatocytes in vivo. Gene Ther. 3:1996;137-144.
6. Wu H., Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:1993;314-322.
7. Staats H., Nichols W., Palker T.J. Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:1996;462-472.
8. Gallichan W., Rosenthal K.L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine. 13:1995;1589-1595.
9. Wiktor TJ. Tissue culture methods. In: Kaplan M, Koprowski H (Eds.), Laboratory techniques in rabies, vol. 23. 2nd ed. Geneva: World Health Organization Monograph, 1973. p. 101-20.
10. Wiktor T.J., Dietzschold B., Leamson N., Koprowski H. Induction and biological properties of defective interfering particles of rabies virus. J. Virol. 21:1977;626-633.
11. Xiang Z., Spitalnik S., Tran M., Wunner W., Cheng J., Ertl H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
12. Wang Y., Xiang Z.Q., Pasquini S., Ertl H.C.J. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J. Virol. 71:1997;3677-3683.
13. Hopkins S., Kraehenbuhl J., Schodel F., Potts A., Peterson D., DeGrandi P., Nardelli-Haefliger D. A recombinant Salmonella typimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:1995;3279-3286.
14. Haneberg B., Kendall D., Amerongen H., Apter F., Kraehenbuhl J., Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:1994;15-23.
15. Kuklin N., Daheshiam M., Karem K., Maniskan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA. J. Virol. 71:1997;3138-3145.
16. Lubeck M.D., Natuk R., Myagkikh M., Kalyan N., Aldrich K., Sinangil F., Alipanah S., Murthy S.C.S., Chanda P.K., Nigida S.M. Jr., Markham P.D., Zolla-Pazner S., Steimer K., Wade M., Reitz M.S. Jr., Arthur L.O., Mizutani S., Davis A., Hung P.P., Gallo R.C., Eichberg J., Robert-Guroff M. Long-term protection of chimpanzees against high dose HIV-1 challenge induced by immunization. Nat. Med. 3:1997;651-658.
17. Staats H.F., Montgomery S.P., Palker T.J. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti HIV antibody responses. AIDS Res. Hum. Retroviruses. 13:1997;945-952.
18. Simon R.H., Engelhardt J.F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J.M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4:1993;771-780.